Rubric Capital Management (New York)’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $635K | Sell |
867,800
-4,390,954
| -83% | -$3.21M | 0.01% | 62 |
|
|
2025
Q1 | $4.24M | Hold |
5,258,754
| – | – | 0.08% | 57 |
|
|
2024
Q4 | $7.26M | Sell |
5,258,754
-5,141,246
| -49% | -$7.09M | 0.09% | 57 |
|
|
2024
Q3 | $10.8M | Hold |
10,400,000
| – | – | 0.18% | 52 |
|
|
2024
Q2 | $18M | Hold |
10,400,000
| – | – | 0.47% | 46 |
|
|
2024
Q1 | $24.9M | Buy |
10,400,000
+10,004,793
| +2,532% | +$23.9M | 0.73% | 43 |
|
|
2023
Q4 | $1.32M | Buy |
+395,207
| New | +$1.32M | 0.03% | 55 |
|
|
2020
Q2 | – | Sell |
-1,583,061
| Closed | -$25.7M | – | 55 |
|
|
2020
Q1 | $25.7M | Sell |
1,583,061
-543,019
| -26% | -$8.81M | 4.06% | 7 |
|
|
2019
Q4 | $38.3M | Buy |
2,126,080
+88,550
| +4% | +$1.59M | 4.33% | 6 |
|
|
2019
Q3 | $41.3M | Buy |
2,037,530
+1,337,530
| +191% | +$27.1M | 3.78% | 4 |
|
|
2019
Q2 | $15.5M | Sell |
700,000
-1,940,771
| -73% | -$42.9M | 1.22% | 29 |
|
|
2019
Q1 | $36M | Sell |
2,640,771
-409,229
| -13% | -$5.58M | 3.36% | 11 |
|
|
2018
Q4 | $27.6M | Buy |
3,050,000
+2,420,000
| +384% | +$21.9M | 3.42% | 11 |
|
|
2018
Q3 | $10.4M | Buy |
630,000
+288,510
| +84% | +$4.76M | 1.1% | 31 |
|
|
2018
Q2 | $4.78M | Sell |
341,490
-121,906
| -26% | -$1.71M | 0.47% | 31 |
|
|
2018
Q1 | $5.12M | Buy |
+463,396
| New | +$5.12M | 0.48% | 41 |
|